Olesia Ignatenko

Olesia Ignatenko

Auto-generated profile, based on publicly available information

Olesia Ignatenko

Department of Neurology and Neuroscience, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
OIOlesia Ignatenko
Olesia Ignatenko
SMSatu Malinen
Satu Malinen
SRSofiia Rybas
Sofiia Rybas
HVHelena Vihinen
Helena Vihinen
JNJoni Nikkanen
Joni Nikkanen
ASAnu Suomalainen
Anu Suomalainen
Astrocytes, often considered as secondary responders to neurodegeneration, are emerging as primary drivers of brain disease. Here we show that mitochondrial DNA depletion in astrocytes affects their primary cilium, the signaling organelle of a cell. The progressive oxidative phosphorylation deficiency in astrocytes induces FOXJ1 and RFX transcription factors, known as master regulators of motile ciliogenesis. Consequently, a robust gene expression program involving motile cilia components and multiciliated cell differentiation factors are induced. While the affected astrocytes still retain a single cilium, these organelles elongate and become remarkably distorted. The data suggest that chronic activation of the mitochondrial integrated stress response (ISRmt) in astrocytes drives anabolic metabolism and promotes ciliary elongation. Collectively, our evidence indicates that an active signaling axis involving mitochondria and primary cilia exists and that ciliary signaling is part of ISRmt in astrocytes. We propose that metabolic ciliopathy is a novel pathomechanism for mitochondria-related neurodegenerative diseases.

4 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
OIOlesia Ignatenko
Olesia Ignatenko
DCDmitri Chilov
Dmitri Chilov
IPIlse Paetau
Ilse Paetau
EMElena de Miguel
Elena de Miguel
CJChristopher B. Jackson
Christopher B. Jackson
ASAnu Suomalainen
Anu Suomalainen
Mitochondrial dysfunction manifests as different neurological diseases, but the mechanisms underlying the clinical variability remain poorly understood. To clarify whether different brain cells have differential sensitivity to mitochondrial dysfunction, we induced mitochondrial DNA (mtDNA) depletion in either neurons or astrocytes of mice, by inactivating Twinkle (TwKO), the replicative mtDNA helicase. Here we show that astrocytes, the most abundant cerebral cell type, are chronically activated upon mtDNA loss, leading to early-onset spongiotic degeneration of brain parenchyma, microgliosis and secondary neurodegeneration. Neuronal mtDNA loss does not, however, cause symptoms until 8 months of age. Findings in astrocyte-TwKO mimic neuropathology of Alpers syndrome, infantile-onset mitochondrial spongiotic encephalopathy caused by mtDNA maintenance defects. Our evidence indicates that (1) astrocytes are dependent on mtDNA integrity; (2) mitochondrial metabolism contributes to their activation; (3) chronic astrocyte activation has devastating consequences, underlying spongiotic encephalopathy; and that (4) astrocytes are a potential target for interventions.

13 October 2025 in Nature Cell Biology
Verified
Journal Article
Open access
MNMai Nguyen
Mai Nguyen
JCJack J. Collier
Jack J. Collier
OIOlesia Ignatenko
Olesia Ignatenko
GMGenevieve Morin
Genevieve Morin
VGVanessa Goyon
Vanessa Goyon
HMHeidi M. McBride
Heidi M. McBride
Mitochondrial control of cell death is of central importance to disease mechanisms from cancer to neurodegeneration. Mitochondrial anchored protein ligase (MAPL) is an outer mitochondrial membrane small ubiquitin-like modifier ligase that is a key determinant of cell survival, yet how MAPL controls the fate of this process remains unclear. Combining genome-wide functional genetic screening and cell biological approaches, we found that MAPL induces pyroptosis through an inflammatory pathway involving mitochondria and lysosomes. MAPL overexpression promotes mitochondrial DNA trafficking in mitochondrial-derived vesicles to lysosomes, which are permeabilized in a process requiring gasdermin pores. This triggers the release of mtDNA into the cytosol, activating the DNA sensor cGAS, required for cell death. Additionally, multiple Parkinson’s disease-related genes, including VPS35 and LRRK2 , also regulate MAPL-induced pyroptosis. Notably, depletion of MAPL, LRRK2 or VPS35 inhibited inflammatory cell death in primary macrophages, placing MAPL and the mitochondria–lysosome pathway at the nexus of immune signalling and cell death.

31 July 2020 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
OIOlesia Ignatenko
Olesia Ignatenko
JNJoni Nikkanen
Joni Nikkanen
AKAlexander Kononov
Alexander Kononov
NZNicola Zamboni
Nicola Zamboni
GIGulayse Ince-Dunn
Gulayse Ince-Dunn
ASAnu Suomalainen
Anu Suomalainen
Mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a group of severe, tissue-specific diseases of childhood with unknown pathogenesis. Brain-specific MDS manifests as devastating spongiotic encephalopathy with no curative therapy. Here, we report cell type–specific stress responses and effects of rapamycin treatment and ketogenic diet (KD) in mice with spongiotic encephalopathy mimicking human MDS, as these interventions were reported to improve some mitochondrial disease signs or symptoms. These mice with astrocyte-specific knockout of Twnk gene encoding replicative mtDNA helicase Twinkle (TwKOastro) show wide-spread cell-autonomous astrocyte activation and mitochondrial integrated stress response (ISRmt) induction with major metabolic remodeling of the brain. Mice with neuronal-specific TwKO show no ISRmt. Both KD and rapamycin lead to rapid deterioration and weight loss of TwKOastro and premature trial termination. Although rapamycin had no robust effects on TwKOastro brain pathology, KD exacerbated spongiosis, gliosis, and ISRmt. Our evidence emphasizes that mitochondrial disease treatments and stress responses are tissue- and disease specific. Furthermore, rapamycin and KD are deleterious in MDS-linked spongiotic encephalopathy, pointing to a crucial role of diet and metabolism for mitochondrial disease progression.

4 November 2015 in Genetica
Verified
Journal Article
Closed access
PDF file
OIOlesia M. Ignatenko
Olesia M. Ignatenko
LZLyudmila Zakharenko
Lyudmila Zakharenko
NDNatalia V. Dorogova
Natalia V. Dorogova
SFSvetlana A. Fedorova
Svetlana A. Fedorova

15 November 2014 in Russian Journal of Genetics
Verified
Journal Article
Closed access
PDF file
LZLyudmila Zakharenko
Lyudmila Zakharenko
OIO. M. Ignatenko
O. M. Ignatenko
Data disputing the unique role of transposable elements (TEs) in the induction of intraspecific gonadal dysgenesis (GD) in Drosophila are discussed.